Healthtech Startups

Humla Health operates a staffing platform that connects W-2 nurses directly with health care facilities for per diem shifts and long-term assignments, letting nurses set their own schedules and minimum pay rates. The platform digitizes recruiting, credentialing, and regulatory functions to let facilities staff without traditional agencies or recruiters.

1 investor

Hummingbird operates patient access for healthcare systems, running part or all of the access stack from Epic to the patient call center as a managed service. It benchmarks operations, improves underlying technology, and standardizes processes so providers can focus on care while patients can more easily reach services like scheduling and prescription refills.

1 investor

Hummsa Biotech develops oral small molecule therapeutics targeting chronic metabolic diseases through multi-targeted approaches, aiming to shift treatment from reactive to preventive and regenerative care. The company prioritizes affordability and accessibility across global markets.

1 investor

Grupo Huntington is a reproductive medicine and in vitro fertilization (IVF) clinic group that provides individualized fertility treatments to patients and families in Brazil. It has operated for nearly 30 years, offering assisted reproduction services with psychological support throughout treatment.

1 investor

HVMN is an energy science company that produces Ketone-IQ, a ketone-based performance fuel made in FDA and WADA-compliant facilities for athletes, military personnel, and high performers seeking enhanced mental clarity, physical performance, and recovery.

1 investor

HVR Cardio develops medical devices for cardiovascular applications, drawing on a management team with combined expertise in structural heart technologies and medical device commercialization.

1 investor

HYBRD is a training app for hybrid athletes that combines strength and cardio workouts with personalized training plans. It features an AI coach that adapts to user goals and integrates data from third-party fitness tools.

1 investor

Guangdong Hybribio Biotech is a Chinese developer and supplier of nucleic acid molecular diagnostic products, focused on the R&D, production, and sale of molecular diagnostic reagents and instruments, including HPV genotyping detection kits and gene chips. The company also operates a healthcare arm, including a specialty hospital in Chaozhou offering blood purification, health screening, and chronic disease management services.

1 investor

Hydreight Technologies is a publicly traded company (TSXV: NURS) operating in the mobile healthcare space, with offerings that include on-demand nurse-delivered IV therapy and wellness treatments such as semaglutide. This investor relations page covers financial statements, shareholder meeting documents, and press releases.

1 investor

Hydro Gummy makes gummy-based hydration products designed as an alternative to drinking water, targeting consumers of all ages who struggle with traditional hydration methods. The company focuses on making healthy hydration habits more convenient and enjoyable.

1 investor

Hyfe develops AI-powered cough monitoring technology that continuously and unobtrusively tracks patients' cough patterns over extended periods. Its life sciences offering targets drug development and clinical trials by providing objective, longitudinal cough data.

1 investor

Fantex is a hard surface cleaner formulated to kill up to 99.999% of germs and pathogens within one minute, with residual protection lasting up to 24 hours, suitable for use on all hard surfaces including food preparation areas. The product is tested against international standards and proven effective against bacteria, fungi, and viruses including MRSA, norovirus, and coronavirus.

1 investor

1 investor

Hyperfine develops the Swoop portable, point-of-care MRI system for brain imaging without ionizing radiation, used in clinical and research settings for infants, children, and adults. The company partners with foundations to deploy the technology for neuroimaging in conditions such as hydrocephalus and early brain development monitoring in low- and middle-income countries.

1 investor

Hypherdata operates an e-auction marketplace platform that connects pharmaceutical companies and AI/ML developers with healthcare data providers to procure real-world medical datasets for clinical research, drug development, and AI model training. The platform facilitates competitive bidding for datasets across multiple medical specialties and imaging modalities, including data cleaning, annotation, and privacy compliance services.

1 investor

Hyris provides diagnostic testing solutions and marketplace technology for healthcare facilities and agricultural operations, enabling distributed testing networks managed from a central hub and pathogen detection services.

1 investor

Hangzhou Bangier Orthopedic Hospital (Hangzhou Linping Orthopedic Hospital), established in 2006, is a national health-insurance-designated orthopedic specialty hospital that emphasizes conservative and minimally invasive treatment. It operates six specialized orthopedic centers covering spine, joint and sports medicine, trauma, hand and foot repair, and pediatric bone development, serving patients in the Linping district of Hangzhou, China.

1 investor

Ikonopedia provides a breast imaging software platform for radiologists and patients, featuring structured reporting tools, risk assessment, and closed-loop lesion tracking to ensure comprehensive breast health management and follow-up care.

1 investor

i-Virtual develops Saphere, a video-based vital sign measurement API that uses remote photoplethysmography (rPPG) and AI to extract health metrics like heart rate, respiratory rate, and stress levels from a 30-second selfie, serving wellness apps, insurtech platforms, and connected device makers.

1 investor

i-BrainTech develops neurofeedback technology that helps athletes improve motor skills, focus, and decision-making through personalized training systems informed by neuroscientific research. The company works with professional football clubs to enhance cognitive and physical performance.

1 investor

i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases. It co-creates and invests in biotech startups, operating as part of the Expert Systems integrated accelerator platform.</parameter> <parameter name="hq_city">San Diego

1 investor

i3 develops a hybrid intravascular imaging catheter combining near-infrared fluorescence (NIRF) and ultrasound (IVUS) sensors to provide real-time molecular and structural imaging during coronary interventions. The system enables detection of arterial injury and complications in cardiac catheterization procedures.

1 investor

I Am Mindful develops mental health first-aid toolkits and online resources to teach people coping strategies for managing stress and difficult emotions. The company serves individuals seeking to build proactive mental health skills outside of crisis intervention.

1 investor

1 investor